Orexigen Therapeutics official unsecured creditors committee appointed

By Caroline Salls

Pittsburgh, March 28 – Orexigen Therapeutics, Inc.’s official committee of unsecured creditors was appointed Tuesday by acting Region 3 U.S. Trustee Andrew R. Vara, according to a notice filed with the U.S. Bankruptcy Court for the District of Delaware.

The committee members are Geoffrey J. Lewis and Patrick Healy of indenture trustee Wilmington Savings Fund Society, FSB of Wilmington, Del.; Erin Beesley of McKesson Specialty Health of Scottsdale, Ariz.; and Deny Maric of Young & Rubicam, LLC of New York.

Orexigen is a San Diego-based biopharmaceutical company focused on the treatment of obesity. The company filed for bankruptcy on March 12 under Chapter 11 case number 18-10518.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.